Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 276 participants.
Also called NCT01673204
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose screening
- Phase
- Phase 4
- Enrolled
- 276 participants
- Registry
-
NCT01673204
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01673204. Randomized; double masking; primary purpose screening. Start 2012-10 (registry gives no type); primary completion 2014-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic Nephropathy
- Condition
- Diabetic Nephropathy
- Intervention (Drug)
- Calcitriol
- Intervention (Drug)
- Placebo
- Lead sponsor
- Seoul National University Hospital
Record details
- Record id
cardio:ct-nct01673204- Content hash
b9cffe2a468f653eda08fb4d679f5a70091725beeee149d81e9c2cf6171c5d67